SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-22-255529
Filing Date
2022-09-30
Accepted
2022-09-30 16:17:43
Documents
12
Effectiveness Date
2022-09-30

Document Format Files

Seq Description Document Type Size
1 S-3ASR d379227ds3asr.htm S-3ASR 357632
2 EX-1.2 d379227dex12.htm EX-1.2 143044
3 EX-4.3 d379227dex43.htm EX-4.3 324106
4 EX-5.1 d379227dex51.htm EX-5.1 22693
5 EX-5.2 d379227dex52.htm EX-5.2 12155
6 EX-23.1 d379227dex231.htm EX-23.1 1811
7 EX-FILING FEES d379227dexfilingfees.htm EX-FILING FEES 71296
8 GRAPHIC g379227g01h00.jpg GRAPHIC 31216
9 GRAPHIC g379227g01h07.jpg GRAPHIC 34052
10 GRAPHIC g379227g17a88.jpg GRAPHIC 26425
11 GRAPHIC g379227image001.jpg GRAPHIC 2596
12 GRAPHIC g379227image002.jpg GRAPHIC 1601
  Complete submission text file 0001193125-22-255529.txt   1055605
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-267678 | Film No.: 221284270
SIC: 2834 Pharmaceutical Preparations